Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 2 |
2019 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Akt Pathway Inhibitors.
Curr Top Med Chem. 2020;20(10):883-900. doi: 10.2174/1568026620666200224101808.
Curr Top Med Chem. 2020.
PMID: 32091335
Review.
Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine.
Uko NE, Güner OF, Bowen JP, Matesic DF.
Uko NE, et al.
Anticancer Res. 2019 Oct;39(10):5329-5338. doi: 10.21873/anticanres.13725.
Anticancer Res. 2019.
PMID: 31570426
Item in Clipboard
Discovery and biological activity of computer-assisted drug designed Akt pathway inhibitors.
Uko NE, Güner OF, Barnett LMA, Matesic DF, Bowen JP.
Uko NE, et al.
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3247-3250. doi: 10.1016/j.bmcl.2018.08.006. Epub 2018 Aug 9.
Bioorg Med Chem Lett. 2018.
PMID: 30143420
Item in Clipboard
Modulator of the PI3K/Akt oncogenic pathway affects mTOR complex 2 in human adenocarcinoma cells.
Curless BP, Uko NE, Matesic DF.
Curless BP, et al. Among authors: uko ne.
Invest New Drugs. 2019 Oct;37(5):902-911. doi: 10.1007/s10637-018-0705-7. Epub 2018 Dec 13.
Invest New Drugs. 2019.
PMID: 30542835
Item in Clipboard
Cite
Cite